Skip to content

Clinical study of Qinpi decoction ultrasonic atomization on ocular surface improving refractive and dry eye indexes in myopia patients

Clinical study of Qinpi decoction ultrasonic atomization on ocular surface improving refractive and dry eye indexes in myopia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079674
Enrollment
Unknown
Registered
2024-01-09
Start date
2024-01-11
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia and dry eye

Interventions

Therapy Group:Qinpi decoction ultrasonic atomization on ocular surface
Control Group:Normal saline ultrasonic atomization on ocular surface

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)Aged from18 to 65 years old,gender unlimited;(2)Diagnosed with myopia and dry eye;(3)Had hardly improvement with eyedrops or eye gels and not received internal or external Chinese Traditional Medicine treatments within 3 months;(4)Enrolled participants who sign informed consent after receiving completely explanation;(5)Participants who have a completely understanding of the purpose and significance of this study and are willing to cooperate with medical history collections,physical and auxiliary examinations.

Exclusion criteria

Exclusion criteria: (1)Both eyes diopters=+0.5DS;(2)Patients with acute hemorrhagic/allergic keratoconjunctivitis,eyelid dermatitis, chronic chlamydia trachomatis and other ocular surface diseases,mature cataracts,absolute glaucoma,wet macular degeneration,proliferative diabetic retinopathy,genetic eye diseases and other serious visual impairments;(3)Patients with systemic diseases which affects ocular health.

Design outcomes

Primary

MeasureTime frame
best corrected visual acuity(BCVA);optic axis;cornea fluorescein staining scores;non-invasive tear break-up time;tear secretion(Schirmer's I Test value);red eye scores;ocular surface disease indexes(OSDI);

Secondary

MeasureTime frame
hospital anxiety depression scale(HADS);TCM symptom scores;

Countries

China

Contacts

Public Contactjiangdan

Longhua Hospital Shanghai University of Traditional Chinese Medicine

jiangdan0720@163.com+86 138 0189 7546

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026